Telotristat Etiprate achieves positive top-line results in second phase 3 clinical trial
December 1, 2015
Read the press release >
distributed by |
Marché Fermé -
Autres places de cotation
|
Après clotûre 21:24:35 | |||
113 EUR | +0,62 % | 113,2 | +0,22 % |
25/04 | AVIS D'ANALYSTES DU JOUR : Kering, Carrefour, STMicroelectronics, ArgenX, Ipsen, Accor, Moncler... | |
24/04 | Paris termine en baisse, peu aidée par Kering et Eurofins | AW |
Telotristat Etiprate achieves positive top-line results in second phase 3 clinical trial
December 1, 2015
Read the press release >
distributed by |
Varia. 1 janv. | Capi. | |
---|---|---|
+4,73 % | 9,94 Md | |
+25,77 % | 653 Md | |
+27,00 % | 556 Md | |
-6,55 % | 354 Md | |
+20,54 % | 331 Md | |
+2,73 % | 296 Md | |
+13,09 % | 233 Md | |
+5,46 % | 201 Md | |
-9,61 % | 193 Md | |
-5,87 % | 144 Md |